ERBB4 and amyotrophic lateral sclerosis: Among the 54 investigated patients, they reported that 11 had probable pathogenic mutations, with TBK1 as the most common cause and identified possible pathogenic mutations in ERBB4, expanding our understanding of its significance in ALS/FTD co-occurrence [33].